Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Prostatic Neoplasms 13Brain Neoplasms 12Sarcoma 7Meningioma 6Pancreatic Neoplasms 5Lung Neoplasms 5Glioma 5Esophageal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Glioblastoma 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Solid Tumor, Adult 3Rhabdomyosarcoma 3Head and Neck Neoplasms 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Radiation Injuries 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Liver Neoplasms 2Hodgkin Disease 2Gliosarcoma 2

Interventions

seclidemstat 2Topotecan 2Cyclophosphamide 2selinexor 1pazopanib 1Zoledronic Acid 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myoepithelioma × Proton Therapy × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡